Purchase Order 75D30122P15419
Award Date
9/15/22
Potential Completion Date
9/14/23
Potential Value
$160K
Federal Agency
CDC Pittsburgh
Awardee
Illumina, Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chamblee, GA 30341, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services, Centers for Disease Control and Prevention (CDC) awarded a $247,008.03 firm fixed price purchase order contract to Illumina, Inc., a for-profit manufacturer of genetic sequencing and analysis products. The contract is for the provision of laboratory supplies, with a completion date of May 31, 2024. Illumina has previously received federal awards from agencies such as the National Institutes of Health (NIH), U.S. Department of Agriculture (USDA), and...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $107,368.22 firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract is for the provision of WDPB ILLUMINA LAB SUPPLIES, to be delivered by September 30, 2022. Illumina has a history of providing sequencing systems, reagents, and other supporting products and services to various federal agencies, including...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order contract to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The $144,302.41 contract provides supplies - chemicals to support the agency's research and diagnostics needs. This award does not have a set-aside designation. Illumina has previously been awarded prime federal contracts by agencies such as NIH, USDA,...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $54,367.08 firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for the repair/replacement and advanced support plan for ISEQ equipment, with performance to be completed by August 20, 2028. Illumina has previously provided sequencing systems, consumables, and services to support genomic research and...
This is a federal contract awarded by the Department of Health and Human Services (HHS) to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract has an award value of $229,032 and is a firm fixed-price purchase order with an ultimate completion date of April 10, 2019. The contract does not have a set-aside designation. The award provides for Illumina to deliver various sequencing systems, reagents, consumables, and...
This is a federal contract award to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $101,280.02, was awarded by the Centers for Disease Control and Prevention (CDC) for the provision of a reagent kit. The contract is a firm fixed price purchase order with no set-aside designation. Illumina has previously received prime federal contract awards from agencies such as the National Institutes of Health (NIH), U.S....
The Department of Health and Human Services' National Institutes of Health National Institute of Environmental Health Sciences awarded a firm fixed price delivery order contract valued at $121,353.93 to Illumina, Inc., a for-profit manufacturing company, to provide sequencing and array-based genomic analysis solutions. The contract has a completion date of September 2, 2025 and does not include any set-aside provisions. Illumina has previously received awards from federal agencies such as the...
This is a firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer and provider of sequencing and array-based solutions for genetic and genomic analysis. The contract, valued at $90,090.72, is for the provision of various Illumina sequencing systems, reagents, consumables, and related services to support genomic sequencing and analysis for research and diagnostics purposes. The award is not set-aside and was issued as a Blanket...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm fixed price purchase order to Illumina, Inc., a manufacturer of sequencing and array-based solutions, for the provision of a NEXTSEQ 1000 Sequencing system. The $205,800.00 contract has a completion date of September 30, 2022 and was awarded on August 2, 2022. Illumina has previously received prime federal contracts from agencies such as the National Institutes of Health, Department of...
This is a $101,594.39 firm fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Illumina, Inc., a manufacturer of genetic and genomic analysis instruments and reagents. The contract is for the provision of laboratory supplies, with no set-aside designation. Illumina has an existing Indefinite Delivery Contract with the Department of the Navy Bureau of Medicine and Surgery to support nucleic acid sequencing needs, and has received prior federal contract...